Disruption of response regulator gene, devR, leads to attenuation in virulence of Mycobacterium tuberculosis

FEMS Microbiology Letters

Volumn 231, Issue 2, 2004, Pages 237-245

  Malhotra, Vandana ^a   Sharma, Deepak ^a   Ramanathan, V D ^b   Shakila, H ^b   Saini, Deepak K ^a   Chakravorty, Soumitesh ^a   Das, Taposh K ^a   Li, Qing ^c   Silver, Richard F ^c   Narayanan, P R ^b   Tyagi, Jaya Sivaswami ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b NATIONAL INSTITUTE FOR RESEARCH IN TUBERCULOSIS   (India)

^c CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Attenuation of virulence; DevR DevS two component system; Mycobacterium tuberculosis devR mutant

Indexed keywords

GENE PRODUCT; PROTEIN DEVR; UNCLASSIFIED DRUG;

ALLELE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATTENUATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERIUM CULTURE; BACTERIUM MUTANT; CELL ADHESION; CELL DIVISION; CONTROLLED STUDY; CULTURE MEDIUM; DEVR GENE; GENE DISRUPTION; GENE IDENTIFICATION; GUINEA PIG; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IN VITRO STUDY; LIVER INJURY; LUNG INJURY; LYMPHOCYTE; MONOCYTE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; REGULATOR GENE; SIGNAL TRANSDUCTION; SPLEEN INJURY; WILD TYPE;

BACTERIA (MICROORGANISMS); CAVIA; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 10744233580     PISSN: 03781097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-1097(04)00002-3     Document Type: Article

References (25)

1. Cole S.T., Brosch R., Parkhill J., Garnier T., Churcher C., Harris D., Gordon S.V., Eiglmeier K., Gas S., Barry III C.E., Tekaia F., Badcock K., Bashyam D., Brown D., Chillingworth T., Connor R., Davies R., Devlin K., Feltwell T., Gentles S., Hamlin N., Holroyd S., Hornsby T., Jagels K., Krogh A., McLean J., Moule S., Murphy L., Oliver K., Osborne J., Quail M.A., Rajandream M.A., Rogers J., Rutter S., Seeger K., Skelton J., Squares R., Squares S., Sulston J.E., Taylor K., Whitehead S., Barrell B.G. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature. 393:1998;537-544.
2. Via L.E., Curcic R., Mudd M.H., Dhandayuthpani S., Ullmer R.J., Deretic V. Elements of signal transduction in Mycobacterium tuberculosis: in vitro phosphorylation and in vivo expression of the response regulator MtrA. J. Bacteriol. 178:1996;3314-3321.
3. Himpens S., Locht C., Supply P. Molecular characterization of the mycobacterial SenX3-RegX3 two-component system: evidence for autoregulation. Microbiology. 146:2000;3091-3098.
4. Haydel S.E., Dunlap N.E., Benjamin W.H. Jr. In vitro evidence of two-component system phosphorylation between the Mycobacterium tuberculosis TrcR/TrcS proteins. Microb. Pathog. 26:1999;195-206.
5. Saini, D.K., Malhotra, V., Dey, D., Pant, N., Das, T.K. and Tyagi, J.S. (2004) DevR-DevS is a bonafide two-component system of Mycobacterium tuberculosis that is hypoxia-responsive in the absence of the DNA-binding domain of DevR. Microbiology, in press.
6. Zahrt T.C., Deretic V. An essential two-component signal transduction system in Mycobacterium tuberculosis. J. Bacteriol. 182:2000;3832-3838.
7. Perez E., Samper S., Bordas Y., Guilhot C., Gicquel B., Martin C. An essential role for phoP in Mycobacterium tuberculosis virulence. Mol. Microbiol. 41:2001;179-187.
8. Ewann F., Jackson M., Pethe K., Cooper A., Mielcarek N., Enserguiex D., Gicquel B., Locht C., Supply P. Transient requirement of the PrrA-PrrB two-component system for early intracellular multiplication of Mycobacterium tuberculosis. Infect. Immun. 70:2002;2256-2263.
9. Zahrt T.C., Deretic V. Mycobacterium tuberculosis signal transduction system required for persistent infections. Proc. Natl. Acad. Sci. USA. 98:2001;12706-12711.
10. Sherman D.R., Voskuil M., Schnappinger D., Liao R., Harrell M.I., Schoolnik G.K. Regulation of the Mycobacterium tuberculosis hypoxic response gene encoding α-crystallin. Proc. Natl. Acad. Sci. USA. 98:2001;7534-7539.
11. Dasgupta N., Kapur V., Singh K.K., Jyothisri K., Das T.K., Sachdeva S., Tyagi J.S. Identification and characterization of a two-component system, devR-devS, of Mycobacterium tuberculosis. Tuberc. Lung Dis. 80:2000;141-159.
12. Kinger A.K., Tyagi J.S. Identification and cloning of genes differentially expressed in the virulent strain of Mycobacterium tuberculosis. Gene. 131:1993;113-117.
13. Quandt J., Hynes M.F. Versatile suicide vectors which allow direct selection for gene replacement in gram-negative bacteria. Gene. 127:1993;15-21.
14. Jacobs W.R., Kalpana G.V., Cirillo J.D., Pascopella L., Snapper L.B., Udani R.A., Jones W., Barletta R.G., Bloom B.R. Genetics systems for mycobacteria. Methods Enzymol. 204:1991;537-555.
15. Saini D.K., Pant N., Das T.K., Tyagi J.S. Cloning, overexpression, purification and matrix-assisted refolding of DevS (Rv 3132c) histidine protein kinase of Mycobacterium tuberculosis. Protein Exp. Purif. 25:2002;203-208.
16. Silver R.F., Li Q., Boom W.H., Ellner J.J. Lymphocyte-dependent inhibition of growth of virulent Mycobacterium tuberculosis H37Rv within human monocytes: requirement for CD4+ T-cells in PPD-positive but not in PPD-negative subjects. J. Immunol. 160:1998;2408-2417.
17. Mitchison D.A., Bhatia A.L., Wallace J.G., Selkon J.B., Subbaiah T.V., Lancaster M.C. A comparison of the virulence in guinea pigs of south Indian and British tubercle bacilli. Tubercle. 41:1960;1-22.
18. Chakravorty S., Tyagi J.S. Novel use of guanidinium isothiocyanate in the isolation of Mycobacterium tuberculosis DNA from clinical material. FEMS Microbiol. Lett. 27:2001;113-117.
19. Ramanathan V.D., Jawahar M.S., Paramasivan C.N., Rajaram K., Chandrasekar K., Kumar V., Palanimurugan K., Prabhakar R. A histological spectrum of host responses in tuberculous lymphadenitis. Indian J. Med. Res. 109:1999;212-220.
20. Parish T., Smith D.A., Kendall S., Casali N., Bancroft G.J., Stoker N.G. Deletion of two-component regulatory systems increases the virulence of Mycobacterium tuberculosis. Infect. Immun. 71:2003;1134-1140.
21. Brown, I.N. (1983) Animal models and immune mechanisms in mycobacterial infection. In: Biology of Mycobacteria, Vol. 2 (Ratledge, C. and Stanford, J., Eds.), pp. 173-234. Academic Press, New York.
22. Smith D.W. Protective effect of BCG in experimental tuberculosis. Adv. Tuberc. Res. 22:1985;1-97.
23. Canetti, G. (1955) The histobacteriogenesis of tuberculosis lesions: experimental studies. In: The Tubercle Bacillus in the Pulmonary Lesion of Man, pp. 87-90. Spring, New York.
24. Wayne L.G., Sohaskey C.D. Non replicating persistence of Mycobacterium tuberculosis. Annu. Rev. Microbiol. 55:2001;139-163.
25. Boon C., Dick T. Mycobacterium bovis BCG response regulator essential for hypoxic dormancy. J. Bacteriol. 184:2002;6760-6767.